Superiority of conventional intrathecal methotrexate therapy with maintenance over intensive intrathecal methotrexate therapy, unmaintained, or radiotherapy (2000-2500 rads tumor dose) in treatment for meningeal leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/803866

Download in:

View as

General Info

PMID
803866